v3.8.0.1
Equity Compensation (Tables)
9 Months Ended
Sep. 30, 2017
Equity Compensation  
Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted

 

 

 

 

 

 

 

 

Average

 

 

 

Shares Subject

 

Weighted

 

Remaining

 

 

 

to Options

 

Average

 

Contractual

 

 

    

Outstanding

    

Exercise Price

    

Life (Years)

  

Balance at December 31, 2016

 

3,776,405

 

 

11.55

 

 

 

Exercised

 

(1,111,583)

 

 

10.16

 

 

 

Expired

 

(59,552)

 

 

17.50

 

 

 

Forfeited

 

(26,045)

 

 

16.82

 

 

 

Balance at September 30, 2017

 

2,579,225

 

 

11.95

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable options at September 30, 2017

 

2,201,595

 

 

11.58

 

5.2

 

Vested and expected to vest at September 30, 2017

 

2,579,225

 

 

11.95

 

5.5

 

 

Summary of stock options outstanding and exercisable

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted

 

 

 

 

 

 

 

 

Average

 

 

 

Shares Subject

 

Weighted

 

Remaining

 

 

 

to Options

 

Average

 

Contractual

 

 

    

Outstanding

    

Exercise Price

    

Life (Years)

  

Balance at December 31, 2016

 

3,776,405

 

 

11.55

 

 

 

Exercised

 

(1,111,583)

 

 

10.16

 

 

 

Expired

 

(59,552)

 

 

17.50

 

 

 

Forfeited

 

(26,045)

 

 

16.82

 

 

 

Balance at September 30, 2017

 

2,579,225

 

 

11.95

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable options at September 30, 2017

 

2,201,595

 

 

11.58

 

5.2

 

Vested and expected to vest at September 30, 2017

 

2,579,225

 

 

11.95

 

5.5

 

 

The following table summarizes information about stock options outstanding and exercisable at September 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

    

 

 

    

 

    

Weighted-

    

 

    

Weighted-

 

 

 

 

 

 

Weighted

 

 

 

Average

 

 

 

Average

 

 

 

 

 

 

Average

 

Number of

 

Remaining

 

Number of

 

Remaining

 

 

 

 

 

 

Exercise

 

Underlying

 

Contractual

 

Underlying

 

Contractual

 

Range of Exercise Prices

    

Price

    

Shares

    

Life (in years)

    

Shares

    

Life (in years)

  

$

3.59

-

6.14

 

 

5.98

 

875,988

 

3.7

 

875,988

 

3.7

 

$

6.34

-

9.93

 

 

8.42

 

359,858

 

5.8

 

287,269

 

5.1

 

$

11.28

-

16.97

 

 

13.79

 

783,732

 

6.7

 

542,383

 

6.6

 

$

17.66

-

22.92

 

 

20.99

 

559,647

 

6.3

 

495,955

 

6.3

 

 

 

 

 

 

 

 

 

2,579,225

 

 

 

2,201,595

 

 

 

 

Summary of aggregate intrinsic-value of options exercised, exercisable, and vested and expected to vest

The following table summarizes the aggregate intrinsic-value of options exercised, exercisable and vested and expected to vest (in thousands):

 

 

 

 

 

 

 

 

 

 

 

For the Nine Months Ended

 

 

 

and as of September 30,

 

 

    

2017

    

2016

 

Options Exercised

 

$

8,927

 

$

2,978

 

Options Exercisable

 

 

39,360

 

 

10,491

 

Options Vested and Expected to Vest

 

 

45,152

 

 

11,065

 

 

Summary of restricted stock unit activity

 

 

 

 

 

 

 

 

 

Number of

 

Weighted Average

 

 

    

Shares

    

Grant Date Fair Value

 

Non-vested balance at December 31, 2016

 

1,396,387

 

 

7.60

 

Awarded

 

782,310

 

 

11.26

 

Vested

 

(746,819)

 

 

7.65

 

Forfeited

 

(57,917)

 

 

8.66

 

Non-vested balance at September 30, 2017

 

1,373,961

 

 

9.61

 

 

Schedule of total stock-based compensation expense classified in Statements of Operations

Total stock-based compensation expense has been classified as follows in the accompanying Condensed Consolidated Statements of Operations (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

    

2017

    

2016

    

2017

    

2016

 

Cost of revenue

 

$

66

 

$

38

 

$

185

 

$

128

 

Research and development

 

 

1,031

 

 

789

 

 

3,210

 

 

2,493

 

Sales and marketing

 

 

883

 

 

496

 

 

2,831

 

 

1,605

 

General and administrative

 

 

1,048

 

 

660

 

 

2,965

 

 

1,707

 

Total stock-based compensation expense

 

$

3,028

 

$

1,983

 

$

9,191

 

$

5,933